Skip to content
PIL Logo

Lyxumia Solution for Injection

Last Updated on eMC 21-Aug-2014 View document  | SANOFI Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21-Aug-2014 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects

Updated on 15-Oct-2013 and displayed until 21-Aug-2014

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Addition of black triangle

Updated on 12-Feb-2013 and displayed until 15-Oct-2013

Reasons for adding or updating:

  • New PIL for new product

Company contact details

SANOFI

Company image
Address

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK

Fax

+44 (0)1483 535 432

Medical Information e-mail
Telephone

+44 (0)1483 505 515

Medical Information Direct Line

+44 (0)845 372 7101

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

lixisenatide

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue